Similar articles

• Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.

  Muhamed G, Greenbaum E, Zakay-Rones Z. Muhamed G, et al. Isr Med Assoc J. 2006 Mar;8(3):155-8. Isr Med Assoc J. 2006. PMID: 16599048
• [Vaccination of children against influenza].

  Pressler K, Sattler HJ, Schöck V. Pressler K, et al. Z Kinderheilkd. 1975;118(4):265-9. Z Kinderheilkd. 1975. PMID: 1130119 German.
• Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.

  Fedson DS, Fulk RV, Huber MA, Reisberg MA, Kasel JA. Fedson DS, et al. J Immunol. 1971 Sep;107(3):730-7. J Immunol. 1971. PMID: 4999093 No abstract available.
• Immunogenicity and protective efficacy of influenza vaccination.

  Hannoun C, Megas F, Piercy J. Hannoun C, et al. Virus Res. 2004 Jul;103(1-2):133-8. doi: 10.1016/j.virusres.2004.02.025. Virus Res. 2004. PMID: 15163501 Review. No abstract available.
• [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].

  Shvartsman IaS, Tsybul'skaia NV, Ispolatova AV. Shvartsman IaS, et al. Usp Sovrem Biol. 1982 Nov-Dec;94(3):446-60. Usp Sovrem Biol. 1982. PMID: 6186100 Review. Russian. No abstract available.